Allegis Investment Advisors LLC bought a new position in shares of Morgan Stanley (NYSE:MS) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,923 shares of the financial services provider’s stock, valued at approximately $206,000.
A number of other institutional investors also recently bought and sold shares of the stock. Dimensional Fund Advisors LP grew its holdings in Morgan Stanley by 18.3% during the third quarter. Dimensional Fund Advisors LP now owns 11,816,768 shares of the financial services provider’s stock worth $569,213,000 after acquiring an additional 1,828,697 shares during the period. Epoch Investment Partners Inc. grew its holdings in Morgan Stanley by 2.0% in the third quarter. Epoch Investment Partners Inc. now owns 9,843,789 shares of the financial services provider’s stock valued at $474,175,000 after purchasing an additional 189,953 shares during the period. Legal & General Group Plc grew its holdings in Morgan Stanley by 1.8% in the third quarter. Legal & General Group Plc now owns 6,800,716 shares of the financial services provider’s stock valued at $327,595,000 after purchasing an additional 116,997 shares during the period. LSV Asset Management grew its holdings in Morgan Stanley by 2.9% in the fourth quarter. LSV Asset Management now owns 6,117,877 shares of the financial services provider’s stock valued at $321,005,000 after purchasing an additional 174,300 shares during the period. Finally, Schwab Charles Investment Management Inc. grew its holdings in Morgan Stanley by 1.4% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 5,937,332 shares of the financial services provider’s stock valued at $311,452,000 after purchasing an additional 84,528 shares during the period. 86.63% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Alistair Darling sold 3,850 shares of Morgan Stanley stock in a transaction that occurred on Friday, November 24th. The stock was sold at an average price of $49.29, for a total transaction of $189,766.50. Following the transaction, the director now owns 14,218 shares in the company, valued at $700,805.22. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Keishi Hotsuki sold 25,000 shares of Morgan Stanley stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $50.00, for a total value of $1,250,000.00. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.
Morgan Stanley (NYSE:MS) last announced its quarterly earnings data on Thursday, January 18th. The financial services provider reported $0.84 EPS for the quarter, topping the Zacks’ consensus estimate of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. The firm had revenue of $9.50 billion for the quarter, compared to the consensus estimate of $9.25 billion. During the same quarter last year, the business posted $0.81 earnings per share. The firm’s revenue was up 5.3% compared to the same quarter last year. analysts forecast that Morgan Stanley will post 4.51 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Wednesday, January 31st will be given a dividend of $0.25 per share. The ex-dividend date is Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.92%. Morgan Stanley’s payout ratio is 32.36%.
MS has been the topic of several research analyst reports. Oppenheimer reissued a “hold” rating on shares of Morgan Stanley in a report on Tuesday, October 17th. BMO Capital Markets reissued a “top pick” rating and issued a $69.00 price objective on shares of Morgan Stanley in a report on Wednesday, October 18th. Buckingham Research raised their price objective on Morgan Stanley from $54.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, October 18th. Barclays raised their price objective on Morgan Stanley from $48.00 to $52.00 and gave the company an “equal weight” rating in a report on Wednesday, October 18th. Finally, Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $56.00 target price on the stock in a research report on Friday, October 20th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $54.07.
About Morgan Stanley
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.